A review of published reports on neuroprotection in spinal cord injury

Spinal Cord

Volumn 47, Issue 10, 2009, Pages 716-726

  Onose, G ^a   Anghelescu, A ^a   Muresanu, D F ^b   Padure, L ^c   Haras, M A ^a   Chendreanu, C O ^a   Onose, L V ^d   Mirea, A ^a   Ciurea, A V ^a   El Masri, W S ^e   Von Wild, K R H ^f  

^a Clinic Hospital Bagdasar Arseni Bucharest   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c National Clinical Center for Pediatric Rehabilitation   (Romania)

^d Medical Service of Metrorex   (Romania)

^e Midland Ctr for Spinal Injuries   (United Kingdom)

^f INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Neuroprotection; Neuroregeneration; Recovery; SCI

Indexed keywords

ANTIBODY; ANTIGEN; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; COLLAGEN ANTIBODY; ENZYME; EPHRIN RECEPTOR A4; GLATIRAMER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE RECEPTOR; HORMONE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; IRON CHELATING AGENT; LAMININ GAMMA1; LAZAROID; LITHIUM; LYSYLASPARTYLISOLEUCINE GAMMA 1 OF LAMININ KAINAT DOMAIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEURITE PROMOTING FACTOR; NEUROTROPHIC FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN INHIBITOR; PROTEIN NOGO; RHO FACTOR; SCAVENGER; SEROTONIN RECEPTOR; TRIPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; CELL SUBPOPULATION; CLINICAL TRIAL; GLIA CELL; HUMAN; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PUBLICATION; REVIEW; SPINAL CORD INJURY; TISSUE INJURY;

ANIMALS; CYTOPROTECTION; HUMANS; INTERDISCIPLINARY COMMUNICATION; NERVE DEGENERATION; NERVE REGENERATION; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; NEUROSCIENCES; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TRANSLATIONAL RESEARCH;

EID: 70349754322     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.52     Document Type: Review

References (68)

1. http://www.travisroyfoundation.org/pages/resources-stats.htm
2. http://www.spinalcord.uab.edu/show.asp?durki=116979&site= 1021&return=19775.
3. Blight AR, Decrescito V. Morphometric analysis of experimental spinal cord injury in the cat; the relation of injury intensity to survival of myelinated axons. Neuroscience 1986; 19: 321-341. (Pubitemid 16053649)
4. Fehlings MG, Baptiste DC. Current status of clinical trials for acute spinal cord injury. Injury 2005; 36(Suppl 2): B113-B122.
5. Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004; 1: 80-100. (Pubitemid 46589342)
6. Mureşanu D. Neuroprotection and Neuroplasticity - Two Aspects of a Continuous Process, Genetically Regulated and Powered by Neurotrophic Factors. The 6th AMN Congress. Cluj-Napoca, Romania, 2008.
7. Young W. Collaborative neurosciences and biological therapy of spinal cord injured people. Summer School for the Biological Treatment of Chronic Spinal Cord Injury; October 2008; Vienna, Austria, 2008.
8. http://clinicaltrials.gov.
9. http://www.chem.qmul.ac.uk/iupac/AminoAcid.
10. Moykkinen T, Liebkind R, Sjoberg J, Korpi Esa R, Liesi P. The neuroprotective KDI domain of γ1 laminin is a universal and potent inhibitor of ionotropic glutamate receptors. J Neurosci Res 2005; 81: 797-804. (Pubitemid 41532145)
11. Liesi P, Laatikainen T, Wright JM. Biologically active sequence (KDI) mediates the neurite outgrowth function of the gamma-1 chain of laminin-1. J Neurosci Res 2001; 66: 1047-1053. (Pubitemid 33135589)
12. Liebkind R, Laatikainen T, Liesi P. Is the soluble KDI domain γ1 laminin a regeneration factor for the mammalian central nervous system? J Neurosci Res 2003; 73: 637-643.
13. Wiksten M, Vaananen AJ, Liebkind R, Liesi P. Regeneration of adult rat spinal cord is promoted by the soluble KDI domain of γ1 laminin. J Neurosci Res 2004; 78: 403-410. (Pubitemid 39488264)
14. Kartje GL, Schulz MK, Lopez-Yunez A, Schnell L, Schwab ME. Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat. Ann Neurol 1999; 45: 778-786. (Pubitemid 29260755)
15. Buchli AD, Schwab ME. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005; 37: 556-567.
16. Weinmann O, Schnell L, Ghosh A, Montani L, Wiessner C, Wannier T et al. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Moll Cell Neurosci 2006; 32: 161-173. (Pubitemid 43868104)
17. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003; 38: 201-211. (Pubitemid 36555647)
18. Fouad K, Klusman I, Schwab ME. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur J Neurosci 2004; 20: 2479-2482. (Pubitemid 39472410)
19. Freund P, Wannier T, Schmidlin E, Bloch J, Mir A, Schwab ME et al. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol 2007; 502: 644-659. (Pubitemid 46732514)
20. Vyas AA, Blixt O, Paulson JC, Schnaar RL. Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in vitro. J Biol Chem 2005; 280: 16305-16310. (Pubitemid 40616758)
21. Yang LJ, Lorenzini I, Vajn K, Mounterey A, Schraam LP, Schnaar RL. Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci USA 2006; 103: 11057-11062. (Pubitemid 44148417)
22. Whitaker CM, Beaumont E, Wells MJ, Magnuson DS, Hetman M, Onifer SM. Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury. Neurosci Lett 2008; 438: 200-204.
23. Nikulina E, Tidwell JL, Dai HN, Bregman Barbara S, Filbin Marie T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci USA 2004; 101: 8786-8791. (Pubitemid 38745849)
24. Qiu J, Cai D, Dai H, McAtee M, Hoffman PN, Bregman BS et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002; 34: 895-903. (Pubitemid 34722280)
25. McKerracher L, Winton MJ. Targeting Rho to stimulate repair after spinal cord injury. Top Spinal Cord Inj Rehabil 2003; 8: 69-75. (Pubitemid 36374023)
26. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640. (Pubitemid 34406764)
27. Caggiano AO, Zimber MP, Ganguly A, Blight AR, Gruskin EA. Chondroitinase ABC improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 2005; 22: 226-239. (Pubitemid 40333517)
28. www.neuraxo.com/cordaneurin.0.html?&L=2.
29. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 2004; 24: 10064-10073. (Pubitemid 39492030)
30. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003; 348: 1365-1375.
31. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
32. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Moll Cell 2002; 9: 459-470. (Pubitemid 34273778)
33. Colak A, Karaoglan A, Barut S, Kokturk S, Akyildiz AI, Tasyurekli M. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2005; 2: 327-334.
34. Ozawa H, Keane RW, Marcillo AE, Diaz PH, Dietrich WD. Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats. Exp Neurol 2002; 177: 306-313. (Pubitemid 35356843)
35. Yakovlev AG, Faden AI. Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 2004; 1: 5-16.
36. Sribnick EA, Matzelle DD, Banik NL, Ray SK. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem Res 2007; 32: 2210-2216.
37. Nam DH, Lee KS, Kim SH, Kim SM, Jung SY, Chung SH et al. Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors. Bioorg Med Chem Lett 2008; 18: 205-209.
38. Kontogeorgakos VA, Voulgaris S, Korompilias AV, Vekris M, Polyzoidis KS, Bourantas K et al. The efficacy of erythropoietin on acute spinal cord injury. An experimental study on a rat model. Arch Orthop Trauma Surg 2009; 129: 189-194.
39. Coleman TR, Wetenfelder C, Togel FE, Yang Y, Hu Z, Swenson L et al. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA 2006; 103: 5965-5970.
40. Lapchak PA. Carbamylated erythropoietin to treat neuronal injury: new development strategies. Expert Opin Investig Drugs 2008; 17: 1175-1186.
41. Grijalva I, Guízar-Sahagún G, Castañeda- Hernández G, Mino D, Maldonado-Julián H, Vidal-Cantú G et al. Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial. Pharmacotherapy 2003; 23: 823-834. (Pubitemid 36875665)
42. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009; 373: 732-738.
43. Nógrádi A, Szabó A, Pintér S, Vrbová G. Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neuroscience 2007; 144: 431-438. (Pubitemid 44873042)
44. Schwab J. Experimental strategies to promote spinal cord regeneration - an integrative perspective. The 7th International Symposium on Experimental Spinal Cord Repair and Regeneration. Brescia, Italy, 2009.
45. Byrnes KR, Waynant RW, Ilev IK, Wu X, Barna L, Smith K. et al. Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. Lasers Surg Med 2005; 36: 171-185. (Pubitemid 40502813)
46. von Wild K, Rabischong P, Brunelli G, Benichou M, Krishnan K. Computer added locomotion by implanted electrical stimulation in paraplegic patients (SUAW). Acta Neurochir Suppl 2002; 79: 99-104.
47. Shapiro S, Borgens R, Pascuzzi R, Roos K, Groff M, Purvines S et al. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J Neurosurg Spine 2005; 2: 3-10.
48. Belci M, Catley M, Husain M, Frankel HL, Davey NJ. Magnetic brain stimulation can improve clinical outcome in incomplete spinal cord injured patients. Spinal Cord 2004; 42: 417-419. (Pubitemid 38969652)
49. Lapointe NP, Guertin PA. Synergistic effects of D1/5 and 5-HT1A/7 receptor agonists on locomotor movement induction in complete spinal cord-transected mice. J Neurophysiol 2008; 100: 160-168.
50. Jordan L. Brainstem and spinal neural systems for the initiation of locomotion. Summer School for the Biological Treatment of Chronic Spinal Cord Injury; October 2008; Vienna, Austria, 2008.
51. Deliagina T. Spinal and supraspinal postural networks. Summer School for the Biological Treatment of Chronic Spinal Cord Injury. October 2008; Vienna, Austria, 2008.
52. Rossignol S. CPG in the recovery of locomotion after partial spinal cord lesions. Summer School for the Biological Treatment of Chronic Spinal Cord Injury; October 2008; Vienna, Austria, 2008.
53. Lyalka VF, Musienko PE, Orlovsky GN, Grillner S, Deliagina TG. Effect of intrathecal administration of serotoninergic and noradrenergic drugs on postural performance in rabbits with spinal cord lesions. J Neurophysiol 2008; 100: 723-732.
54. Dasen JS, Tice BC, Brenner-Morton S, Jessell TM. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 2005; 123: 477-491. (Pubitemid 41546677)
55. Song M-R, Pfaff SL. Hox genes: the instructors working at motor pools. Cell 2005; 123: 363-365.
56. Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res 2006; 1070: 124-130. (Pubitemid 43247751)
57. Onose G, Padure L (eds). Compendiu de Neuroreabilitare - la adulti, copii si varstnici (Compendium of Neurorehabilitation - In Adults, Children and Elderly), Cap. 2. Editura Universitara Carol Davila: Bucharest, 2008, pp 21-87.
58. Onose G, Anghelescu A, Chendreanu C, Mihailescu C, Lapadat M, Mihaescu A-S et al. Standing and gait recovery in hemiplegic patients: outcome comparative analysis between postural reflexes/reactions stimulation versus classical prorioceptive facilitation method. The 31st National Annual Congress of Physical and Rehabilitation Medicine, Poiana Braşov, Romania, 29 October-1 November 2008, 2009.
59. Hultborn H. Plasticity at motoneuronal level following spinal cord lesions. Summer School for the Biological Treatment of Chronic Spinal Cord Injury. October 2008; Vienna, Austria, 2008.
60. Dobkin B, Apple D, Barbeau H, Basso M, Behrman A, Deforge D et al. Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI. Neurology 2006; 66: 484-493. (Pubitemid 43739872)
61. Lavrov I, Dy CJ, Fong AJ, Gerasimenko Y, Courtine G, Zhong H et al. Epidural stimulation induced modulation of spinal locomotor networks in adult spinal rats. J Neurosci 2008; 28: 6022-6029.
62. Minassian K, Jilge B, Rattay F, Pinter MM, Binder H, Gerstenbrand F et al. Stepping-like movements in humans with complete spinal cord injury induced by epidural stimulation of lumbar cord: electromyographic study of compound muscle action potentials. Spinal Cord 2004; 42: 401-416. (Pubitemid 38969651)
63. Minassian K, Persy I, Rattay F, Pinter MM, Kern H, Dimitrijevic MR. Human lumbar cord circuitries can be activated by extrinsic input tonic to generate locomotor-like activity. Hum Mov Sci 2007; 26: 275-295. (Pubitemid 46444718)
64. Brunelli G, von Wild KRH. Unsuspected plasticity of single neurons after connection of the cortico-spinal tract with peripheral nerves in spinal cord lesions. Korean J Neurosurg 2009; 46: 1.
65. Von Wild KRH, Brunelli GA. Restoration of paraplegics with aid of autologous bypass grafts for direct neurotisation of muscles by upper motor neurons-the future: surgery of the spinal cord? Acta Neurochir Suppl 2003; 87: 107-112.
66. Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004; 10: 610-616.
67. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 2005; 25: 1169-1178. (Pubitemid 40268958)
68. Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J. Combining an autologous nervous system bridge and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 2006; 26: 7405-7415. (Pubitemid 44315209)